Literature DB >> 24410125

The incidence of postoperative hyponatremia and associated neurological sequelae in children with intracranial neoplasms.

Cydni N Williams1, Jennifer S Belzer, Jay Riva-Cambrin, Angela P Presson, Susan L Bratton.   

Abstract

OBJECT: Intracranial tumors are common pediatric neoplasms and account for substantial morbidity among children with cancer. Hyponatremia is a known complication of neurosurgical procedures and is associated with higher morbidity among neurosurgical patients. The authors aimed to estimate the incidence of hyponatremia, identify clinical characteristics associated with hyponatremia, and assess the association between hyponatremia and patient outcome among children undergoing surgery for intracranial tumors.
METHODS: This is a retrospective cohort study of children ranging in age from 0 to 19 years who underwent an initial neurosurgical procedure for an intracranial tumor between January 2001 and February 2012. Hyponatremia was defined as serum sodium ≤ 130 mEq/L during admission.
RESULTS: Hyponatremia during admission occurred in 39 (12%) of 319 patients and was associated with young age and obstructive hydrocephalus (relative risk [RR] 2.9 [95% CI 1.3-6.3]). Hyponatremic patients were frequently symptomatic; 21% had seizures and 41% had altered mental status. Hyponatremia was associated with complicated care including mechanical ventilation (RR 4.4 [95% CI 2.5-7.9]), physical therapy (RR 4 [95% CI 1.8-8.8]), supplemental nutrition (RR 5.7 [95% CI 3.3-9.8]), and infection (RR 5.7 [95% CI 3.3-9.5]). Hyponatremic patients had a 5-fold increased risk of moderate or severe disability on the basis of their Pediatric Cerebral Performance Category score at discharge (RR 5.3 [95% CI 2.9-9.8]). Obstructive hydrocephalus (adjusted odds ratio [aOR] 3.24 [95% CI 1.38-8.94]) and young age (aOR 0.92 [95% CI 0.85-0.99]) were independently associated with hyponatremia during admission. Hyponatremia was independently associated with moderate or worse disability by Pediatric Cerebral Performance Category score at discharge (aOR 6.2 [95% CI 3.0-13.03]).
CONCLUSIONS: Hyponatremia was common, particularly among younger children and those with hydrocephalus. Hyponatremia was frequently symptomatic and was associated with more complicated hospital courses. Hyponatremia was independently associated with worse neurological outcome when adjusted for age and tumor factors. This study serves as an exploratory analysis identifying important risk factors for hyponatremia and associated sequelae. Further research into the causes of hyponatremia and the association with poor outcome is needed to determine if prevention and treatment of hyponatremia can improve outcomes in these children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24410125     DOI: 10.3171/2013.12.PEDS13364

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  6 in total

Review 1.  Neurological Complications of Pediatric Cancer.

Authors:  Elizabeth C Neil; Sharyu Hanmantgad; Yasmin Khakoo
Journal:  J Child Neurol       Date:  2015-12-29       Impact factor: 1.987

2.  The authors reply.

Authors:  Alexis A Topjian; Stuart H Friess
Journal:  Pediatr Crit Care Med       Date:  2015-02       Impact factor: 3.624

3.  Seizure outcomes of supratentorial brain tumor resection in pediatric patients.

Authors:  Fadi S Saadeh; Edward F Melamed; Nolan D Rea; Mark D Krieger
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

Review 4.  Impact of perioperative hyponatremia in children: A narrative review.

Authors:  Cheme Andersen; Arash Afshari
Journal:  World J Crit Care Med       Date:  2014-11-04

5.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

6.  Management and consequences of postoperative fluctuations in plasma sodium concentration after pediatric brain tumor surgery in the sellar region: a national cohort analysis.

Authors:  R W J Kruis; A Y N Schouten-van Meeteren; M J J Finken; W Oostdijk; A S P van Trotsenburg; A M Boot; H L Claahsen-van der Grinten; E J van Lindert; K S Han; E W Hoving; E M C Michiels; H M van Santen
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.